Vaccines
Compatibility and Stability of a Shigella Polysaccharide-Protein Conjugate Antigen Formulated with Aluminum Salt and CpG 1018® Adjuvants.
Poorva Taskar, Prashant Kumar, Brandy Dotson, Anup Datta, Shangdong Guo, Giriraj Chalke, Richa Puri, Harshita Seth, Benjamin Wizel, Sangeeta B Joshi, David B Volkin
Published: 202510.3390/vaccines14010010
Abstract
This study evaluated the formulation and stability of a quadrivalent glycoconjugate Shigella vaccine candidate based on four predominant strains (S. flexneri; 2a, 3a, and 6, and S. sonnei) covering ~64% of global Shigella infections. Each glycoconjug…
Preview only. Read the full abstract at the source